BioCardia Inc. (NASDAQ: BCDA) filed a pre-submission with the Food and Drug Administration seeking approval for its Helix Transendocardial Delivery ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE